Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
European Journal of Medicinal Chemistry
|
June 27, 2026
Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniques
Jörg Berghausen, Ganesh Rajaraman, Sujal Deshmukh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 18, 2010
The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs
Peter B Tarsa, Christopher S Towler, Grahame Woollam, et al.
Chemmedchem
|
April 21, 2016
Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold
Marianne Fouché, Michael Schäfer, Markus Blatter, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2015
Orally bioavailable Syk inhibitors with activity in a rat PK/PD model
Gebhard Thoma, Siem Veenstra, Ross Strang, et al.
Chemmedchem
|
May 8, 2016
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure
Marianne Fouché, Michael Schäfer, Jörg Berghausen, et al.
Pharmaceutical Research
|
December 24, 2014
Ionic liquid versus prodrug strategy to address formulation challenges
Anja Balk, Toni Widmer, Johannes Wiest, et al.
Journal of Medicinal Chemistry
|
September 14, 2024
Discovery and <i>In Vivo</i> Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors
Juraj Velcicky, Matthias R Bauer, Achim Schlapbach, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4
Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
European Journal of Medicinal Chemistry
|
June 27, 2026
Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniques
Jörg Berghausen, Ganesh Rajaraman, Sujal Deshmukh
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 18, 2010
The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs
Peter B Tarsa, Christopher S Towler, Grahame Woollam, et al.
Chemmedchem
|
April 21, 2016
Pharmacokinetic Studies around the Mono- and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold
Marianne Fouché, Michael Schäfer, Markus Blatter, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 1, 2015
Orally bioavailable Syk inhibitors with activity in a rat PK/PD model
Gebhard Thoma, Siem Veenstra, Ross Strang, et al.
Chemmedchem
|
May 8, 2016
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure
Marianne Fouché, Michael Schäfer, Jörg Berghausen, et al.
Pharmaceutical Research
|
December 24, 2014
Ionic liquid versus prodrug strategy to address formulation challenges
Anja Balk, Toni Widmer, Johannes Wiest, et al.
Journal of Medicinal Chemistry
|
September 14, 2024
Discovery and <i>In Vivo</i> Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors
Juraj Velcicky, Matthias R Bauer, Achim Schlapbach, et al.
Journal of Medicinal Chemistry
|
September 15, 2020
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4
Robin A Fairhurst, Thomas Knoepfel, Nicole Buschmann, et al.
Page
of 1